- Home
- CBL vs NKTR Comparison
CBL vs NKTR Comparison
Compare CBL & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CBL | NKTR |
|---|---|---|
| Founded | 1978 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 1993 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CBL | NKTR |
|---|---|---|
| Price | $35.74 | $56.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $45.00 | ★ $106.33 |
| AVG Volume (30 Days) | 150.3K | ★ 633.8K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | ★ 5.04% | N/A |
| EPS Growth | ★ 297.30 | N/A |
| EPS | ★ 4.02 | N/A |
| Revenue | ★ $553,643,000.00 | $62,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.87 | ★ N/A |
| Revenue Growth | ★ 5.74 | N/A |
| 52 Week Low | $21.10 | $6.48 |
| 52 Week High | $35.80 | $66.92 |
Technical Indicators
Market Signals| Indicator | CBL | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 76.20 | 47.67 |
| Support Level | $33.22 | $53.55 |
| Resistance Level | $35.80 | $66.86 |
| Average True Range (ATR) | 0.69 | 4.04 |
| MACD | 0.23 | -0.36 |
| Stochastic Oscillator | 96.99 | 25.82 |
Price Performance
Historical ComparisonAbout CBL CBL & Associates Properties Inc.
CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.